As of 2025-04-21, the EV/EBITDA ratio of Moderna Inc (MRNA) is -2.32. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRNA's latest enterprise value is 7,690.31 mil USD. MRNA's TTM EBITDA according to its financial statements is -3,312.00 mil USD. Dividing these 2 quantities gives us the above MRNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.3x - 13.4x | 11.0x |
| Forward P/E multiples | 6.9x - 9.7x | 7.8x |
| Fair Price | (75.19) - (78.44) | (75.92) |
| Upside | -404.2% - -417.4% | -407.2% |
| Date | EV/EBITDA |
| 2025-04-17 | -2.32 |
| 2025-04-16 | -2.38 |
| 2025-04-15 | -2.50 |
| 2025-04-14 | -2.57 |
| 2025-04-11 | -2.50 |
| 2025-04-10 | -2.30 |
| 2025-04-09 | -2.55 |
| 2025-04-08 | -2.31 |
| 2025-04-07 | -2.43 |
| 2025-04-04 | -2.37 |
| 2025-04-03 | -2.44 |
| 2025-04-02 | -2.67 |
| 2025-04-01 | -2.61 |
| 2025-03-31 | -2.75 |
| 2025-03-28 | -3.07 |
| 2025-03-27 | -3.19 |
| 2025-03-26 | -3.11 |
| 2025-03-25 | -3.39 |
| 2025-03-24 | -3.43 |
| 2025-03-21 | -3.25 |
| 2025-03-20 | -3.22 |
| 2025-03-19 | -3.33 |
| 2025-03-18 | -3.38 |
| 2025-03-17 | -3.49 |
| 2025-03-14 | -3.48 |
| 2025-03-13 | -3.44 |
| 2025-03-12 | -3.52 |
| 2025-03-11 | -3.38 |
| 2025-03-10 | -3.63 |
| 2025-03-07 | -3.59 |
| 2025-03-06 | -3.44 |
| 2025-03-05 | -3.55 |
| 2025-03-04 | -2.98 |
| 2025-03-03 | -2.97 |
| 2025-02-28 | -3.05 |
| 2025-02-27 | -3.07 |
| 2025-02-26 | -3.36 |
| 2025-02-25 | -3.32 |
| 2025-02-24 | -3.39 |
| 2025-02-21 | -3.58 |
| 2025-02-20 | -3.37 |
| 2025-02-19 | -3.63 |
| 2025-02-18 | -3.61 |
| 2025-02-14 | -3.29 |
| 2025-02-13 | -3.16 |
| 2025-02-12 | -3.00 |
| 2025-02-11 | -3.05 |
| 2025-02-10 | -3.16 |
| 2025-02-07 | -3.24 |
| 2025-02-06 | -3.36 |